Nothing Special   »   [go: up one dir, main page]

ES2168279T3 - Utilizacion de linfocitos transformados con virus herpes saimiri en un procedimiento para la multiplicacion de virus del tipo hiv que causan inmunodeficiencia. - Google Patents

Utilizacion de linfocitos transformados con virus herpes saimiri en un procedimiento para la multiplicacion de virus del tipo hiv que causan inmunodeficiencia.

Info

Publication number
ES2168279T3
ES2168279T3 ES94102613T ES94102613T ES2168279T3 ES 2168279 T3 ES2168279 T3 ES 2168279T3 ES 94102613 T ES94102613 T ES 94102613T ES 94102613 T ES94102613 T ES 94102613T ES 2168279 T3 ES2168279 T3 ES 2168279T3
Authority
ES
Spain
Prior art keywords
multiplication
procedure
hiv type
type viruses
transformed lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94102613T
Other languages
English (en)
Inventor
Sigrid Dr Nick
Helmut Dr Fickenscher
Brigitte Dr Biesinger-Zwosta
Gerhard Prof Dr Jahn
Bernhard Prof Dr Fleckenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2168279T3 publication Critical patent/ES2168279T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DA A CONOCER UN PROCESO PARA LA MULTIPLICACION DE VIRUS QUE ORIGINAN UNA DEBILIDAD INMUNOLOGICA DEL TIPO HIV, DONDE SE UTILIZAN LINFOCITOS QUE SON TRANSFORMADOS CON EL VIRUS DE HERPES SAIMIRI.
ES94102613T 1993-03-12 1994-02-22 Utilizacion de linfocitos transformados con virus herpes saimiri en un procedimiento para la multiplicacion de virus del tipo hiv que causan inmunodeficiencia. Expired - Lifetime ES2168279T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4307970A DE4307970A1 (de) 1993-03-12 1993-03-12 Verwendung von mit Herpesvirus saimiri transformierten Lymphozyten in einem Verfahren zur Vermehrung von Immunschwäche verursachenden Viren vom HIV-Typ

Publications (1)

Publication Number Publication Date
ES2168279T3 true ES2168279T3 (es) 2002-06-16

Family

ID=6482679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94102613T Expired - Lifetime ES2168279T3 (es) 1993-03-12 1994-02-22 Utilizacion de linfocitos transformados con virus herpes saimiri en un procedimiento para la multiplicacion de virus del tipo hiv que causan inmunodeficiencia.

Country Status (10)

Country Link
US (1) US5656475A (es)
EP (1) EP0614969B1 (es)
JP (1) JPH06319544A (es)
AT (1) ATE209676T1 (es)
AU (1) AU669422B2 (es)
CA (1) CA2118843A1 (es)
DE (2) DE4307970A1 (es)
DK (1) DK0614969T3 (es)
ES (1) ES2168279T3 (es)
PT (1) PT614969E (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5765172A (en) * 1996-01-23 1998-06-09 Dsc Communications Corporation System and method for verifying integrity of replicated databases
ATE240398T1 (de) 1997-07-11 2003-05-15 Fleckenstein Bernard Prof Dr Von kaposi-sarkom assoziiertem herpes-virus (kshv,hhv-8) kodiertes polypeptid und dessen verwendung in diagnostik und therapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04503300A (ja) * 1988-10-06 1992-06-18 デイナ・フアーバー・キヤンサー・インステイテユート Ｈ．ｓａｉｍｉｒｉ―ｈｔｌｖ―ｘ領域ベクター

Also Published As

Publication number Publication date
EP0614969B1 (de) 2001-11-28
CA2118843A1 (en) 1994-09-13
JPH06319544A (ja) 1994-11-22
PT614969E (pt) 2002-05-31
ATE209676T1 (de) 2001-12-15
AU5773194A (en) 1994-09-15
DE59409970D1 (de) 2002-01-10
AU669422B2 (en) 1996-06-06
EP0614969A2 (de) 1994-09-14
DK0614969T3 (da) 2002-03-18
EP0614969A3 (en) 1995-11-15
US5656475A (en) 1997-08-12
DE4307970A1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ES2112270T3 (es) Anticuerpo de recombinacion especifica del cd4.
ZA905953B (en) Albumin derivatives with therapeutic functions
ES2105522T3 (es) Elemento de fijacion con inicio de rosca efectivo.
DE3774936D1 (de) Plasmabrenner mit einstellbarer kathode.
AR245684A1 (es) Procedimiento mejorado de hidrogenolisis/deshidrohalogenacion
FI83880B (fi) Foerfarande foer framstaellning av en polypeptid, som aer anvaendbar vid alstring av immunologiskt gensvar mot herpes simplex-infektioner.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
ES2073469T3 (es) Un metodo para encuadernar materiales usando un encuadernador del tipo de anillas en forma de dientes curvados.
TW224968B (es)
MX9303201A (es) Separador de liquido y gas.
ES546920A0 (es) Procedimiento para desactivar un virus asociado a una frac- cion de plasma que contiene factor viii
ES2110447T3 (es) Sistema de afeitado.
ES2055286T3 (es) Rueda para aviones.
NO880288D0 (no) Plasmalanse.
ES2187504T3 (es) Vectores no oncovirales, basados en el vmmp, con encapsidacion defectuosa.
ITTO920133A1 (it) Separatore
ES2159654T3 (es) Procedimiento para la preparacion de copolimeros vinilaromaticos reforzados con caucho.
ES2168279T3 (es) Utilizacion de linfocitos transformados con virus herpes saimiri en un procedimiento para la multiplicacion de virus del tipo hiv que causan inmunodeficiencia.
DE68907102D1 (de) Plasmabrenner.
NO940810L (no) Behandling av virusinfeksjoner
MX9304148A (es) Composicion mejorada para el costado de neumaticos.
MX9305992A (es) Modificacion con laser de superficies de objectos a traves de ablacion.
ES2152630T3 (es) Compuestos antivirales.
ES2136689T3 (es) Procedimiento para la obtencion de metalocenos en un solo paso de reaccion.
AU4569393A (en) Anti-feline immunodeficiency virus (fiv) vaccines

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 614969

Country of ref document: ES